Invesaro

Stocks NYAX Financial statements

Financial statements

Nayax Ltd. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Nayax Ltd. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2020FY2022FY2022FY2023FY2024FY2025
Revenue78.8119174235314400
Cost of revenue41.671113147172207
Gross profit37.248.26088.3142193
Research and development9.31922.121.925.430
Selling, general and administrative26.545.464.170.398.2121
Operating income-2.22-22.5-34-12.43.1137.6
Interest expense3.871.663.464.7810.913.7
Interest income0.442.493.4110.7
Pre-tax income-6.1-24.1-37.1-14.7-4.3834.6
Income tax-0.020.630.451.221.25-0.95
Net income to minority interests0.17-0.0100
Net income-6.08-24.8-37.5-15.9-5.6335.5
EBITDA-0.66-20.3-30.7-7.9410.646.2
EPS, basic-0.25-0.82-1.14-0.48-0.160.96
EPS, diluted-0.25-0.82-1.14-0.48-0.160.94

Balance sheet

FY2020FY2022FY2022FY2023FY2024FY2025
Cash and equivalents8.287.333.938.483.1320
Receivables19.327.441.355.7104
Inventory7.6923.820.619.828.6
Total current assets156150203288620
Property, plant and equipment5.056.236.675.4911.120.4
Lease right-of-use assets4.765.287.385.346.298.91
Total assets216230324433853
Short-term debt07.6847.525.30
Total current liabilities70.2110204219274
Lease liabilities5.155.395.944.154.086.4
Total liabilities84.3126226268622
Retained earnings-28.7-56.6-65.6-63.3-19.6
Shareholders' equity132105
Total equity12.513210597.6165231
Total liabilities and equity216230324433853

Cash flow statement

FY2020FY2022FY2022FY2023FY2024FY2025
Net income-6.08-24.8-37.5-15.9-5.6335.5
Depreciation and amortization1.562.23.374.447.488.66
Cash from operations6.49-12.8-27.58.842.940.3
Capital expenditures-2.13-2.64-1.52-0.61-3.08-5.33
Cash from investing-8.57-22.6-26.5-36.8-45.9-78.7
Debt issued4.73-1.970022.80
Debt repaid-0.92-2.18-2.58-3.63-3.840
Stock issued013300
Cash from financing6.051146.2131.650.8266
Exchange rate effect-0.220.63-6.190.91-2.6911.2
Net change in cash3.9678.7-47.93.5247.8227
Free cash flow4.36-15.4-29.18.1939.835

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $45.03 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin48.2%Gross profit / revenue.
Operating margin9.4%Operating income / revenue.
EBITDA margin11.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin8.6%Pre-tax income / revenue.
Net margin8.9%Net income / revenue.
FCF margin8.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin10.1%Cash from operations / revenue.
Effective tax rate-2.7%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)5.5%Net income / average total assets.
R&D / revenue7.5%Research and development expense / revenue.
SG&A / revenue30.3%Selling, general and administrative expense / revenue.
Capex / revenue1.3%Capital expenditures / revenue.
D&A / revenue2.2%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y27.5%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y32.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y38.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y36.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y47.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y39.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y1,110.0%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y336.5%EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y-6.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y44.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-12.2%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y51.6%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y97.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y54.7%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.26xCurrent assets / current liabilities.
Quick ratio1.54x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.16x(Cash + short-term investments) / current liabilities.
Liabilities / assets72.9%Total liabilities / total assets.
Interest coverage2.75xOperating income / interest expense.
Working capital$345.7MCurrent assets - current liabilities.

Efficiency

MetricValueHow it is calculated
Asset turnover0.62xRevenue / average total assets.
Fixed asset turnover25.4xRevenue / average property, plant and equipment.
Inventory turnover8.58xCost of revenue / average inventory.
Days inventory43 days365 x average inventory / cost of revenue.
Receivables turnover5.02xRevenue / average receivables.
Days sales outstanding73 days365 x average receivables / revenue.
FCF conversion98.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow13.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.94Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$0.96Net income per basic share, as reported (split-adjusted).

Valuation

MetricValueHow it is calculated
Market cap$1.68BShare price x shares outstanding.
Enterprise value$1.36BMarket cap + total debt - cash - short-term investments.
P/E47.4xMarket cap / net income. Only when net income is positive.
P/S4.20xMarket cap / revenue.
P/FCF48.1xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF41.8xMarket cap / cash from operations, when positive.
EV/Sales3.40xEnterprise value / revenue.
EV/EBIT36.3xEnterprise value / operating income, when both are positive.
EV/EBITDA29.5xEnterprise value / EBITDA, when both are positive.
EV/FCF39.0xEnterprise value / free cash flow, when both are positive.
FCF yield2.1%Free cash flow / market cap.
Earnings yield2.1%Net income / market cap (the inverse of P/E).
What was Nayax Ltd.'s revenue in fiscal 2025?

Nayax Ltd. reported revenue of $400.4M for fiscal 2025, 27.5% higher than the year before.

Was Nayax Ltd. profitable in fiscal 2025?

Yes. Net income was $35.5M, a net margin of 8.9%.

How much free cash flow did Nayax Ltd. generate in fiscal 2025?

Cash from operations of $40.3M minus capital expenditures of $5.3M left free cash flow of $35.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Nayax Ltd.